Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?
Cancer immunotherapy is one of the hottest areas of cancer research these days, and the market looks to be worth billions. Which big pharma do we think will be the biggest winner in the space?
Clinton Proposals Could Spell Trouble for These 3 Drugmakers
An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.